Louielyn V.

Paragas Drug Study

Generic Name Camphene Brand Name Rowatinex Dosage

BSN 301 Group 3

1 tab TID

Contraindicati ons st Urolithiasis, 1 trimester of nephrolithiasis pregnancy , cystitis, renal colic, UTI,postop prophylaxis of calcul Oral (cefuroxime axetil) Pharyngitis, tonsillitis caused by Streptococcus pyogenes Otitis media caused by Streptococcus pneumonia, S. pyogenes, Haemophilus influenza, Moraxella catarrhalis Acute bacterial maxillary sinusitis caused by S. Allergy to cephalosporins or penicillin.

Indications

Side Effects No side effects have been reported

Cefuroxime

Ceftin, Zinacef

750 mg IV q 8 (-)ANST

Headache, dizziness, lethargy, paresthesias, nausea, vomiting, diarrhea, anorexia, abdominal pain, flatulence, pseudomembra nous colitis, hepatotoxixity, nephrotoxicity, bone marrow depression, pain, abscess at injection site, phlebitis, inflammation at IV site, superinfection,

Nursing Responsibility Liquid intake should be increased during therapy. Store at temperatures not exceeding 30 degrees Celsius. Culture infection site, and arrange for sensitivity tests before and during therapy if expected response is not seen give oral drug with food to decrease GI upset and enhance absorption. give oral tablets to children who can swallow tablets, crushing the drug results to a bitter, unpleasant taste. Use solution for children who cant

pneumoniae, H. influenzae Lower respiratory Infections caused by by S. pneumoniae, H. influenzae, Haemophilus parainfluenza e UTis caused by Eschiricia coli, Klebsiella pneumoniae Uncomplicat ed gonorrhoea (urethral and endocervical) Skin and skin structure infections including impetigo caused by Streptococcus aureus, S. pyogenes Treatment of early Lyme disease Parenteral (Cefuroxime sodium)

disulfram like reaction with alcohol.

swallow tablets. Have vitamin K available in case hypoprothrombin emia occurs. Discontinue if hypersensitivity reaction occurs.

Lower respiratory infections, dermatologic infections, UTI, uncomplicate d and disseminated gonorrhea, septicimia, Meningitis, Bone and joint infections, Perioperative prophylaxis, Treatment of acute bacterial maxillary sinusitis in patients 3mo12yr Ceftriaxone sodium Rocephin 2gm IV now then 0.0 ANST (-) Lower respiratory infections, acute bacterial otitis media, UTI, gonorrhoea, PID, Skin and skin structure infections, septicaemia, bone and joint Allergy to caphalosporins or penicillin Headache, dizziness, lethargy, paresthesias, nausea, vomiting, diarrhea, anorexia, abdominal pain, flatulence, pseudomembra nous colitis, Culture infection site, and arrange for sensitivity tests before and during therapy if expected response is not seen Reconstitute for IM use with sterile water for injection, 0.9%

infections, meningitis, perioperative prophylaxis for patients undergoing coronary artery bypass surgery and in contaminated or potentially contaminated surgical procedures.

hepatotoxixity, nephrotoxicity, bone marrow depression, pain, abscess at injection site, phlebitis, inflammation at IV site, superinfection, disulfram like reaction with alcohol.

sodium chloride solution, 5% dextrose solution, bacteriostatic water with 0.9% benzyl alcohol, or 1% lidocaine solution (without epinephrine); inject deeply into a large muscle group. Check manufacturers inserts for specific details. Stability of reconstituted and diluted solution depends on diluents, concentration and type of container. Protect drug from light Do not mix ceftriaxone with any other antimicrobial drug. Monitor ceftriaxone blood levels in patients with severe renal impairments and in patients with renal and hepatic

impairment. Have vitamin K available in case hypoprothrombin emia occurs. Discontinue if hypersensitivity reaction occurs.